While certain polymorphisms in NAT and GST genes with established associations with bladder cancer susceptibility have been well-studied (reviewed in [47]), understanding the complexity associated with bladder cancer risk and prognosis requires a better understanding of other SNPs in distinct populations. The gene discussed is BRD2; the disease is urinary bladder carcinoma.